Yemaachi Biotechnology
PrivateLast Round
Grant
Mar 6, 2024
Est. Valuation
$1.79M
Total Funding Raised
$4.13M
Company Overview
Yemaachi Biotechnology is a precision oncology company that leverages African genomic diversity to develop next-generation cancer diagnostics and therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yemaachi Biotechnology Comparables
Compare Yemaachi Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Syndicate Bio | 78% | |
| MyAfroDNA | 78% | |
| Pahtia Technologies | 73% | |
Yemaachi Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 6, 2024 | ||||
| Seed | Mar 21, 2022 | ||||
| Grant | Oct 20, 2021 | ||||
| Accelerator | Aug 9, 2021 |
Yemaachi Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Cancer Grand Challenges | Grant |
| LifeLine Financial Group | Seed |
| LoftyInc Capital Management | Seed |
| Cancer Research UK | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Y Combinator | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 18, 2025
Launching The African Cancer Atlas (TACA) together.
- Feb 18, 2025
Launched The African Cancer Atlas in partnership with Roche.
Yemaachi Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Yemaachi Biotechnology's valuation, stock price, and market status.